Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.

Bouchard S, MacKenzie TC, Radu AP, Hayashi S, Peranteau WH, Chirmule N, Flake AW.

J Gene Med. 2003 Nov;5(11):941-50.

PMID:
14601131
2.

[Development of adenoviral vectors in gene therapy: application to gene transfer in muscles].

Ragot T, Perricaudet M.

C R Seances Soc Biol Fil. 1996;190(1):13-31. Review. French.

PMID:
8881265
3.

Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.

Couto LB.

Semin Thromb Hemost. 2004 Apr;30(2):161-71. Review.

PMID:
15118928
4.

Adenovirus mediated gene transfer to skeletal muscle.

Cao B, Mytinger JR, Huard J.

Microsc Res Tech. 2002 Jul 1;58(1):45-51. Review.

PMID:
12112422
5.
6.

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.

Jooss K, Chirmule N.

Gene Ther. 2003 Jun;10(11):955-63. Review.

PMID:
12756416
7.

Gene transfer and models of gene therapy for the myocardium.

Alexander MY, Webster KA, McDonald PH, Prentice HM.

Clin Exp Pharmacol Physiol. 1999 Sep;26(9):661-8. Review.

PMID:
10499153
8.

Strategies for long-term expression of transgenes in the respiratory epithelium.

Gill DR, Bazzani RP, Hyde SC.

Curr Opin Mol Ther. 2010 Aug;12(4):386-93. Review.

PMID:
20677089
9.

Recent advances in skeletal-muscle-based gene therapy.

Marshall DJ, Leiden JM.

Curr Opin Genet Dev. 1998 Jun;8(3):360-5. Review.

PMID:
9691001
10.

Antivector and antitransgene host responses in gene therapy.

Hackett NR, Kaminsky SM, Sondhi D, Crystal RG.

Curr Opin Mol Ther. 2000 Aug;2(4):376-82. Review.

PMID:
11249767
11.

Recombinant adeno-associated virus vector design and gene expression in the mammalian brain.

Paterna JC, Büeler H.

Methods. 2002 Oct;28(2):208-18. Review.

PMID:
12413419
12.

Helper-dependent adenoviral vectors in experimental gene therapy.

Józkowicz A, Dulak J.

Acta Biochim Pol. 2005;52(3):589-99. Epub 2005 Aug 4. Review.

13.

Non-viral gene delivery in skeletal muscle: a protein factory.

Lu QL, Bou-Gharios G, Partridge TA.

Gene Ther. 2003 Jan;10(2):131-42. Review.

PMID:
12571642
14.

Direct gene transfer into muscle.

Danko I, Wolff JA.

Vaccine. 1994 Dec;12(16):1499-502. Review.

PMID:
7879413
15.

Critical aspects of viral vectors for gene transfer into the kidney.

Favre D, Ferry N, Moullier P.

J Am Soc Nephrol. 2000 Nov;11 Suppl 16:S149-53. Review.

16.

Progress and prospects: immune responses to viral vectors.

Nayak S, Herzog RW.

Gene Ther. 2010 Mar;17(3):295-304. doi: 10.1038/gt.2009.148. Epub 2009 Nov 12. Review. Erratum in: Gene Ther. 2010 Feb;17(2):294.

17.

Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Lopez-Gordo E, Podgorski II, Downes N, Alemany R.

Hum Gene Ther. 2014 Apr;25(4):285-300. doi: 10.1089/hum.2013.228. Epub 2014 Mar 25. Review.

18.

Controlling the kinetics of interferon transgene expression for improved gene therapy.

Watcharanurak K, Nishikawa M, Takahashi Y, Takakura Y.

J Drug Target. 2012 Nov;20(9):764-9. doi: 10.3109/1061186X.2012.716848. Epub 2012 Sep 20. Review.

PMID:
22994266
19.

Skeletal muscle as an artificial endocrine tissue.

Goldspink G.

Best Pract Res Clin Endocrinol Metab. 2003 Jun;17(2):211-22. Review.

PMID:
12787548
20.

Intramuscular injection of plasmid DNA.

Wells DJ.

Mol Cell Biol Hum Dis Ser. 1995;5:83-103. Review. No abstract available.

PMID:
9532562

Supplemental Content

Support Center